On Jan. 20, 2026, investors weigh ImmunityBio’s sharp rally on new FDA feedback around its bladder cancer plans.

After closing out the preceding week at a record high, the S&P 500 clocked a new record high close of 6,977.27 on Monday, 12 ...

US stocks got clobbered on Tuesday in Wall Street's worst day since October, returning to the kind of tariff-fueled routs ...

Early eczema trial success and heavy trading are rapidly reshaping how investors view this drug developer, today, Jan. 20, 2026.

US stocks posted hefty losses Tuesday after President Trump reignited trade-war tensions with Europe over Greenland, while a ...

NetApp NTAP cratered nearly 9% in heavy volume after Morgan Stanley downgraded the data storage and hardware stock to ...

The Nifty fell 0.36 per cent to 25,141, while the Sensex declined 0.47 per cent to 81,794.65 as of 9.15 am IST. The Nifty and ...

All ​three major Wall Street indexes ended Tuesday with their biggest one-day drops in three months, in a broad selloff ...

Similarly, the Vanguard Total Stock Market ETF ( VTI) holds a Quant rating of Buy with a slightly lower total score of 3.81, ...

Bank deposits in South Korea are falling sharply as investors shift cash toward the stock market during the KOSPI's rally, ...

The budget proposal calls to bring “alternative nicotine products” under New York’s existing 75% wholesale tax on tobacco products.